rivastigmine has been researched along with Cardiac Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballard, C; Barone, P; Ferrara, R; Lane, R; Tekin, S | 1 |
Gao, M; Wang, JQ; Wang, M; Zheng, QH | 1 |
Anand, R; Graham, S; Hartman, R; Morganroth, J | 1 |
1 review(s) available for rivastigmine and Cardiac Diseases
Article | Year |
---|---|
Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Double-Blind Method; Female; Heart Diseases; Humans; Lewy Body Disease; Male; Middle Aged; Multicenter Studies as Topic; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine | 2006 |
1 trial(s) available for rivastigmine and Cardiac Diseases
Article | Year |
---|---|
Electrocardiographic effects of rivastigmine.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Bradycardia; Carbamates; Cardiovascular System; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Diseases; Heart Rate; Humans; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Tachycardia | 2002 |
1 other study(ies) available for rivastigmine and Cardiac Diseases
Article | Year |
---|---|
Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Carbon Radioisotopes; Cholinesterase Inhibitors; Heart Diseases; Humans; Magnetic Resonance Spectroscopy; Phenylcarbamates; Positron-Emission Tomography; Radiopharmaceuticals; Rivastigmine | 2008 |